Bone Infection Unit, Nuffield Orthopaedic Centre, Windmill Road, Oxford OX3 7LD, UK.
J Antimicrob Chemother. 2010 Mar;65(3):569-75. doi: 10.1093/jac/dkp469. Epub 2010 Jan 6.
We describe rates of success for two-stage revision of prosthetic joint infection (PJI), including data on reimplantation microbiology.
We retrospectively collected data from all the cases of PJI that were managed with two-stage revision over a 4 year period. Patients were managed with an antibiotic-free period before reimplantation, in order to confirm, clinically and microbiologically, that infection was successfully treated.
One hundred and fifty-two cases were identified. The overall success rate (i.e. retention of the prosthesis over 5.75 years of follow-up) was 83%, but was 89% for first revisions and 73% for re-revisions [hazard ratio = 2.9, 95% confidence interval (CI) 1.2-7.4, P = 0.023]. Reimplantation microbiology was frequently positive (14%), but did not predict outcome (hazard ratio = 1.3, 95% CI 0.4-3.7, P = 0.6). Furthermore, most unplanned debridements following the first stage were carried out before antibiotics were stopped (25 versus 2 debridements).
We did not identify evidence supporting the use of an antibiotic-free period before reimplantation and routine reimplantation microbiology. Re-revision was associated with a significantly worse outcome.
我们描述了二期翻修治疗人工关节感染(PJI)的成功率,包括再植入微生物学数据。
我们回顾性地收集了 4 年内所有接受二期翻修治疗的 PJI 病例的数据。患者在再植入前有一个无抗生素期,以临床和微生物学确认感染得到成功治疗。
共确定了 152 例病例。总体成功率(即 5.75 年以上随访中保留假体)为 83%,但初次翻修的成功率为 89%,再次翻修的成功率为 73%[风险比=2.9,95%置信区间(CI)1.2-7.4,P=0.023]。再植入微生物学通常为阳性(14%),但未预测结局(风险比=1.3,95%CI 0.4-3.7,P=0.6)。此外,大多数首次手术后未计划的清创术是在停止抗生素之前进行的(25 次与 2 次清创术)。
我们没有发现支持在再植入前使用无抗生素期和常规再植入微生物学的证据。再次翻修与明显更差的结局相关。